Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol for Postoperative Sedation
NCT02874768Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dexmedetomidine (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Total perfused small vessel density at 6 hours. Started Aug 2016; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT02874768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02874768.